TE_27464
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L1HS_5end |
---|---|
TE superfamily | L1 |
TE class | LINE |
Gene | -, ENSG00000215398, ENSG00000290354 |
Class | Chimeric, Intergenic |
Coding | Non-coding |
Tumor-specific score | 366.31 |
Counts of samples | TCGA_tumor:324; TCGA_normal:0; GTEx:0 |
TSS | chr14(+):18289476 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_27464.1 | ENSG00000215398, ENSG00000290354 | Chimeric | Non-coding | Non-coding | chr14(+):18289477,18289867,18338243,18338416,18340614,18340726,18341694,18341714 |
teRNA_27464.2 | ENSG00000215398, ENSG00000290354 | Chimeric | Non-coding | Non-coding | chr14(+):18289477,18289867,18338243,18338416,18340614,18340634 |
teRNA_27464.3 | - | Intergenic | Non-coding | Non-coding | chr14(+):18289477,18289867,18332139,18332159 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.